Watch CBS News

Vaping

0910-ctm-bloombergannouncementqa-bloomberg-1930434-640x360.jpg

Bloomberg rips FDA for teen vaping epidemic

The fight against teen vaping and flavored e-cigarettes just got a $160 million boost from Michael Bloomberg. Bloomberg Philanthropies revealed Tuesday morning that it's funding a new program aimed at ending the epidemic of vaping, following a new study that found flavor was the reason most young adults said they started using e-cigarettes. The Campaign for Tobacco-Free Kids will coordinate the push. In their first TV interview, Bloomberg and the president of the Campaign for Tobacco-Free Kids, Matthew Myers, discuss the FDA's role in regulating e-cigarettes, why they are targeting flavored e-cigarette first and how they plan to use the $160 million.

0912-ctm-trumpvaping-reid-1931933-640x360.jpg

The problem with Trump's e-cig crackdown

President Trump says a ban on most flavored vaping products is the right response to what health officials call an "epidemic" of e-cigarette use by teenagers. A recent jump in illnesses linked to vaping has grabbed the attention of lawmakers, regulators, and parents, including the president and first lady. But CBS News has learned any real crackdown is likely a long way off. It will take weeks for the FDA to release its final rule -- and even then, companies have time to respond. Paula Reid reports.

0912-ctm-vapingregulation-agus-1932016-640x360.jpg

Is vaping actually safer than smoking?

The White House is moving to curb the vaping epidemic in America that's linked to at least six recent deaths. A new initiative would ban most flavored e-cigarettes, allowing only tobacco flavor. Cases of possible vaping- related illnesses have been reported in at least 36 states, including Hawaii, Idaho, and Washington, which just reported their first cases this week. Dr. David Agus joins "CBS This Morning" to discuss why we still don't know the full health impact of e-cigarettes and the challenges of regulating them.

Show More
View CBS News In
CBS News App Open
Chrome Safari Continue